- Parents were 38% more likely to regularly offer inhaler medication using the Funhaler device compared with normal spacers, and
- Adherence to recommended spacer technique increased by 60% with the Funhaler.
- Parents expressed preference for the Funhaler over conventional spacers
The Funhaler is included on the Australian Register of Therapeutic Goods. The Funhaler has received US FDA clearance to be marketed in the United States and is CE marked.
Gervase CHANEY, Barry CLEMENTS, Lou LANDAU, Max BULSARA and Paul WATT . A new asthma spacer device to improve compliance in children: a pilot study.Respirology (2004) 9, 499-506
P M Watt, B Clements, S G Devadason, G M Chaney. Funhaler spacer: improving adherence without compromising delivery. Arch Dis Child 2003;88:579-581